SCHEMBL2277716

SCHEMBL2277716

COCCNS(=O)(=O)c1cccc(CO)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.56
▸ PKM P14618 3/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ TSHR P16473 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ LMNA P02545 3/20 0.55
▸ HPGD P15428 2/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ HTT P42858 4/20 0.54
▸ MAPK1 P28482 1/20 0.52
▸ GAA P10253 2/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ AKR1C3 P42330 4/20 0.47
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13181452 0.87 ALDH1A1 (0.57) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL1348621 0.79 ATM (0.61) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL2788724 0.79 PRMT1 (0.61) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL2281070 0.79 CYP2C19 (0.70) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL4617091 0.78 MAPK1 (0.61) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL6567085 0.78 MAPK1 (0.81) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL8403024 0.77 MAPK1 (0.79) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL2281148 0.77 ALDH1A1 (0.56) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL13155053 0.77 ALDH1A1 (0.56) ALDH1A1PKMKMT2ATSHRMEN1
SCHEMBL13545200 0.77 ALDH1A1 (0.52) ALDH1A1PKMKMT2ATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989478-B2 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-02 — — US disclosed
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 — — US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 — — US disclosed
US-20060211680-A1 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-21 — — US disclosed
EP-1671961-A1 CINNAMOYL COMPOUND AND USE OF THE SAME Sumitomo Chemical Company, Limited (JP) 2006-06-21 — — EP disclosed
EP-1671948-A1 CINNAMOYL COMPOUND AND USE OF THE SAME Sumitomo Chemical Company, Limited (JP) 2006-06-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211680-A1 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis COL2A1, COL1A1, COL14A1 ALDH1A1 576/4885PKM 4691/4885KMT2A 3569/4885
US-20070265228-A1 Cinnamoyl compound and use of the same NPC1, CES2, CYP51A1 ALDH1A1 83/4885PKM 3196/4885KMT2A 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback